课题基金 / 基金详情

MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION

MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
大鼠乳腺癌发生——激素预防
批准号:
2654238
负责人:
Satyabrata Nandi
金额:
$26.44万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2002-01-31

项目摘要

项目成果

Satyabrata Nandi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's description) First full term pregnancy during the teen age years in women can permanently reduce their risk for developing breast cancer. In the current proposal, the investigator will thoroughly analyze the causes of parity-related refractoriness to mammary cancer development in rats, and examine the mechanism underlying the protection effect of perphenazine, a drug which causes transient prolactinemia. The proposal includes four Specific Aims: [1] Studies of the refractoriness of parous rats to MNU-induced mammary carcinogenesis, [2] whether the refractoriness is permanent, [3] characterize the perphenazine-induced refractoriness, and [4] the mechanism underlying the perphenazine-induced refractoriness. The long-term goal is to generate an experimental paradigm that can be used to develop strategies for the prevention of human breast cancer without significant alterations in the quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6173700
  • 项目类别:
  • 资助金额:
    $21.83万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6513247
  • 项目类别:
  • 资助金额:
    $23.16万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6376792
  • 项目类别:
  • 资助金额:
    $22.49万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
海外基金